Charles Hitson
Internal Medicine · Griffin, GANPI 1407850480
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 215 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,277 and has fallen 98.8% since, to $15 in 2023.
Across 215 payments — averaging $14.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$483
- Amgen$402
- Pfizer$344
- AstraZeneca$332
- Amarin Pharma, Inc.$214
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$132
- plus $1K from 31 others
What the payments were for
- Food & beverage$3,04297%
- Education$1063%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 29 | $483 |
| Amgen | 31 | $402 |
| Pfizer | 27 | $344 |
| AstraZeneca | 24 | $332 |
| Amarin Pharma, Inc. | 10 | $214 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $132 |
| Johnson & Johnson | 10 | $128 |
| Novo Nordisk | 8 | $120 |
| AbbVie(2 entities) | 8 | $119 |
| Biohaven Pharmaceuticals, Inc. | 6 | $84 |
| Sunovion Pharmaceuticals Inc. | 9 | $79 |
| Boehringer Ingelheim | 5 | $79 |
| Biogen | 3 | $68 |
| Mylan Specialty L.p. | 4 | $58 |
| Lilly USA, LLC | 4 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Avanir Pharmaceuticals, Inc. | 2 | $35 |
| Boston Scientific | 2 | $35 |
| Genentech USA, Inc. | 2 | $28 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Merck | 2 | $27 |
| Novartis | 2 | $26 |
| E.r. Squibb & Sons, L.L.C. | 2 | $25 |
| Shire North American Group Inc | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Bayer | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
| Antares Pharma, Inc. | 1 | $13 |
| Clarus Therapeutics Inc. | 1 | $12 |
| GSK | 1 | $12 |
| Nevro Corp. | 1 | $12 |
| Medtronic | 1 | $12 |
| Smith+Nephew | 1 | $11 |
How this compares
$3,148 in reported general payments places this provider in the 80th percentile of 3,311 internal medicine providers in Georgia.
Other internal medicine in Griffin
- Michael GibsonSmyrna$2.2M
- Eduard FatakhovAlpharetta$376K
- Tracey HenryAtlanta$305K
- Sharon TuckettVilla Rica$265K
- Ebon BourneMarietta$242K
- Jennifer WoehlerSavannah$207K
- Julian HutchinsGreensboro$201K
- Brian PearlmanDalton$199K
- Scott ParryAtlanta$162K
- Jennifer GilliganAtlanta$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.